FR2318644A1 - Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation - Google Patents

Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation

Info

Publication number
FR2318644A1
FR2318644A1 FR7622212A FR7622212A FR2318644A1 FR 2318644 A1 FR2318644 A1 FR 2318644A1 FR 7622212 A FR7622212 A FR 7622212A FR 7622212 A FR7622212 A FR 7622212A FR 2318644 A1 FR2318644 A1 FR 2318644A1
Authority
FR
France
Prior art keywords
fluoteroids
new
application
preparation process
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7622212A
Other languages
English (en)
French (fr)
Other versions
FR2318644B1 (sv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2318644A1 publication Critical patent/FR2318644A1/fr
Application granted granted Critical
Publication of FR2318644B1 publication Critical patent/FR2318644B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7622212A 1975-07-23 1976-07-21 Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation Granted FR2318644A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH962075A CH611631A5 (en) 1975-07-23 1975-07-23 Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids

Publications (2)

Publication Number Publication Date
FR2318644A1 true FR2318644A1 (fr) 1977-02-18
FR2318644B1 FR2318644B1 (sv) 1978-12-15

Family

ID=4353884

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7622212A Granted FR2318644A1 (fr) 1975-07-23 1976-07-21 Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation

Country Status (15)

Country Link
JP (1) JPS5214761A (sv)
AT (1) AT353989B (sv)
AU (1) AU505846B2 (sv)
BE (1) BE844378A (sv)
CH (1) CH611631A5 (sv)
DE (1) DE2632550A1 (sv)
DK (1) DK329976A (sv)
ES (1) ES449989A1 (sv)
FR (1) FR2318644A1 (sv)
GB (1) GB1520356A (sv)
IE (1) IE43926B1 (sv)
NL (1) NL7608141A (sv)
NZ (1) NZ181538A (sv)
SE (1) SE7608369L (sv)
ZA (1) ZA764405B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030615B1 (en) * 1979-11-16 1984-08-29 STEROSYNT Ltd. 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5423643A (en) * 1977-07-22 1979-02-22 Aikawa Tekko Doctor blade stablizing apparatus
FI911202A (fi) * 1990-12-28 1992-06-29 Albany Int Corp Schaberblad.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030615B1 (en) * 1979-11-16 1984-08-29 STEROSYNT Ltd. 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AT353989B (de) 1979-12-10
JPS5214761A (en) 1977-02-03
SE7608369L (sv) 1977-01-24
IE43926L (en) 1977-01-23
BE844378A (fr) 1977-01-24
ES449989A1 (es) 1977-12-01
ZA764405B (en) 1977-08-31
FR2318644B1 (sv) 1978-12-15
GB1520356A (en) 1978-08-09
ATA539376A (de) 1979-05-15
CH611631A5 (en) 1979-06-15
AU505846B2 (en) 1979-12-06
DE2632550A1 (de) 1977-02-10
DK329976A (da) 1977-01-24
NZ181538A (en) 1978-09-20
AU1612176A (en) 1978-01-26
IE43926B1 (en) 1981-07-01
NL7608141A (nl) 1977-01-25

Similar Documents

Publication Publication Date Title
FR2337718A1 (fr) Nouveaux hydroxy-benzodiheterocycles etherifies, leur procede de preparation et leur application en tant que medicaments
FR2329266A1 (fr) Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments
BE849542A (fr) Nouveaux derives de quinazolone, leur preparation et leur utilisation en tant en tant que medicaments
BE781879A (fr) Nouveaux 1,4-dihydropyridines dissymetriques leur procede de preparation et leur application comme medicaments
FR2282893A1 (fr) Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
FR2285864B1 (fr) Nouveaux derives polyeniques, leur procede de preparation et leur application en tant que medicaments
BE845581A (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
MC1223A1 (fr) Nouveaux derives de 2-imino-imidazolidine,leur preparation et leur application en tant que medicaments
FR2351993A1 (fr) Composes 9-(3-o-acyl-b-d-arabinofuranosyl)adeniniques, composes 9-(2,3-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation, et leur application en tant que medicaments
FR2351995A1 (fr) Composes 9-(2-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
FR2285870A1 (fr) Nouveaux derives de benzofurane, leur procede de preparation et leur application en tant que medicaments
FR2294708A1 (fr) Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation
BE847861A (fr) Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments
BE845320A (fr) Nouveaux acides 7beta-(d-2-amino-2-(alcoyl inferieur-sulfonylamino-phenyl) -acetylamino) -3-r-3-cephem-4-carboxyliques, leur procede de preparation et leur application en tant que medicaments
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
BE862275A (fr) Nouveaux acides sulfamoylbenzoiques, leur preparatrion et leur application en tant que medicaments
FR2292472A1 (fr) Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation
FR2275215A1 (fr) Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament
FR2315260A1 (fr) Nouveaux composes araliphatiques dihalogenes, leur application en tant que medicaments et leur procede de preparation
FR2318644A1 (fr) Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
FR2314709A1 (fr) Nouveaux derives alcyniques, leur procede de preparation et leur application en tant que medicaments
FR2309217A1 (fr) Nouveaux phenylalcanols, leur application en tant que medicaments et leur procede de preparation
BE864290A (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
ST Notification of lapse
AM Act modifying the rights related to an application or a patent
TP Transmission of property